dm+d
108675009
Refrigerated Storage
Remicade
Merck Sharp & Dohme LimitedIn the event of an inadvertent temperature excursion the following data may be used:
Remicade may be stored at temperatures up to a maximum of 25 °C for a single period of up to 6 months, but not exceeding the original expiry date.
Contact MSD in cases where additional stability information is required.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Remsima
Celltrion PharmaceuticalsIn the event of an inadvertent temperature excursion the following data may be used:
Pre-filled syringe and pen
In-house stability data shows the product was stable when exposed to 3 cycles of -20±5°C to 20±5°C for a total duration of 12 days.
The product may be stored at temperatures up to a maximum of 25°C for a duration of up to 28 days but not exceeding the original expiry date. Following an excursion, keep the product outside of the fridge.
Vial
In-house stability data shows the product was stable when exposed to -25±5°C for 30 days.
The vials may be stored at temperatures up to a maximum of 25°C for a single period of up to 6 months but not exceeding the original expiry date. In this case, the product should be stored outside of the fridge.
The vials may be kept up to 40°C ± 2°C for 3 months. Following an excursion, keep the product outside of the fridge.
In-house stability data from the manufacturer have shown that unopened vials have demonstrated stability for up to 60 months when exposed to temperature cycling at conditions of -20°C ±5°C to 40°C±2°C for a total period of 12 days.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Inflectra
Hospira UK Ltd (part of Pfizer)In the event of an inadvertent temperature excursion the following data may be used:
Inflectra may be stored at temperatures up to a maximum of 25°C for a single period of up to 6 months, but not exceeding the original expiry date. Keep the product outside of the fridge.
Flixabi
Biogen BiosimilarsIn the event of an inadvertent temperature excursion the following data may be used:
Flixabi is stable for a single period of 6 months when exposed to temperatures of up to 25°C. Flixabi must not be returned to refrigerated storage and the new expiry date must be written on the carton.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Contact Biogen directly for any additional information in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.